EMG
BMY icon

ETF Managers Group’s Bristol-Myers Squibb BMY Stock Holding History

ETF Managers Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$830K Buy
11,980
+2,144
+22% +$151K 0.03% 261
2022
Q4 		$708K Sell
9,836
-2,147
-18% -$162K 0.03% 235
2022
Q3 		$852K Sell
11,983
-19,812
-62% -$1.44M 0.03% 230
2022
Q2 		$2.47M Buy
31,795
+17,192
+118% +$1.31M 0.07% 154
2022
Q1 		$1.07M Sell
14,603
-3,129
-18% -$210K 0.02% 269
2021
Q4 		$1.11M Sell
17,732
-232
-1% -$13.6K 0.02% 269
2021
Q3 		$1.08M Buy
17,964
+2,889
+19% +$190K 0.02% 264
2021
Q2 		$999K Sell
15,075
-24,533
-62% -$1.6M 0.02% 276
2021
Q1 		$2.49M Buy
39,608
+28,526
+257% +$1.77M 0.04% 170
2020
Q4 		$681K Buy
11,082
+561
+5% +$34.5K 0.01% 289
2020
Q3 		$630K Sell
10,521
-5,704
-35% -$343K 0.02% 269
2020
Q2 		$938K Sell
16,225
-2,318
-13% -$139K 0.03% 187
2020
Q1 		$1.01M Buy
18,543
+13,139
+243% +$803K 0.05% 150
2019
Q4 		$344K Buy
5,404
+1,392
+35% +$79.7K 0.01% 321
2019
Q3 		$201K Sell
4,012
-83
-2% -$3.9K 0.01% 416
2019
Q2 		$185K Buy
4,095
+1,799
+78% +$83.8K 0.01% 455
2019
Q1 		$110K Buy
2,296
+210
+10% +$10.5K 0.01% 490
2018
Q4 		$108K Buy
2,086
+328
+19% +$17.6K 0.01% 458
2018
Q3 		$109K Buy
1,758
+184
+12% +$10.9K ﹤0.01% 455
2018
Q2 		$51K Buy
1,574
+276
+21% +$14.9K ﹤0.01% 461
2018
Q1 		$80K Buy
1,298
+162
+14% +$10.4K ﹤0.01% 372
2017
Q4 		$70K Buy
1,136
+162
+17% +$10.1K 0.01% 378
2017
Q3 		$62K Buy
974
+92
+10% +$5.37K 0.01% 229
2017
Q2 		$49K Buy
+882
New +$48K ﹤0.01% 388
2016
Q1 		$23K Buy
+414
New +$26.1K 0.02% 440

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

ETF Managers Group's BMY Position: Q1 2023 in Review

ETF Managers Group increased its Bristol-Myers Squibb (BMY) stake by 22% in Q1 2023, buying an estimated $151K and bringing the position to 11,980 shares worth $830K. The position accounts for 0.03% of the portfolio, ranked #261.

ETF Managers Group first reported a position in BMY in Q1 2016 and has held it in 25 quarters since. The position peaked at $2.49M in Q1 2021. 2,542 funds tracked by Wall St. Rank hold BMY as of Q1 2023.

  • ETF Managers Group held 11,980 shares of Bristol-Myers Squibb worth $830K as of Q1 2023.
  • ETF Managers Group bought 2,144 Bristol-Myers Squibb shares in Q1 2023, an estimated $151K.
  • Bristol-Myers Squibb made up 0.03% of ETF Managers Group's portfolio in Q1 2023, its #261 holding.
  • ETF Managers Group first reported a position in Bristol-Myers Squibb in Q1 2016 and has held it in 25 quarters since.
  • ETF Managers Group's Bristol-Myers Squibb position peaked at $2.49M in Q1 2021.
  • 2,542 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.